SPL — Starpharma Holdings Income Statement
0.000.00%
Last trade - 00:00
- AU$55.59m
- AU$26.59m
- AU$4.21m
- 57
- 34
- 40
- 42
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.72 | 6.56 | 2.15 | 4.9 | 4.21 |
Cost of Revenue | |||||
Gross Profit | 2.47 | 5.67 | 1.36 | 2.12 | 3.09 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17 | 21.8 | 23.2 | 21.3 | 20 |
Operating Profit | -14.3 | -15.2 | -21.1 | -16.4 | -15.8 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.3 | -14.7 | -19.7 | -16.2 | -15.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.3 | -14.7 | -19.7 | -16.2 | -15.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -14.3 | -14.7 | -19.7 | -16.2 | -15.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.3 | -14.7 | -19.7 | -16.2 | -15.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.038 | -0.039 | -0.05 | -0.04 | -0.038 |